MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS
Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…Impact of Deep Brain Stimulation on Fall Risk
Objective: To compare fall risk in Parkinson’s disease patients with and without deep brain stimulation of the subthalamic nucleus. Background: The prevention of falls is…Evaluation of the Body Weight Changes and Food Addiction in Parkinson’s Disease patient with Deep Brain Stimulation
Objective: The aim of this study is to evaluate Parkinson’s disease patient’s body weight changes after Deep Brain Stimulation (DBS) and to search the existence…A day in the life of Parkinson’s: Using passive monitoring to characterize the disease at home
Objective: To characterize the home lives of individuals with Parkinson's disease (PD) using a passive radio wave sensor with a focus on motor, non-motor, and…Transcranial brain sonography can distinguish drug induced parkinsonism from idiopathic Parkinson’s disease in Korean?
Objective: This was a prospective study to evaluate distinction of trans cranial sonograph(TCS) findings of the SN(sustantia nigra) in patients who were recent-onset of durg…Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder
Objective: To investigate the clinical features and associated factors of Parkinson's disease (PD) patients with probable rapid eye movement sleep behavior disorder (PD-pRBD) Background: RBD…Progressive supranuclear palsy: Common metabolic pattern in different variants
Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…The Future of Hospitalization for People with Parkinson’s Disease
Objective: To share the discussion of the December 6, 2019 Parkinson’s Hospitalization Convening. Background: On December 6, 2019, The Parkinson’s Foundation (PF) assembled thought leaders…Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease
Objective: To determine the association between baseline modifiable comorbidities, including cardiovascular disease risk factors, mood disorders, and sleep characteristics, and the rate of change in…Improved verb use in Parkinson’s disease following intensive voice treatment
Objective: To identify changes in language production secondary to voice treatment in speakers with Parkinson’s disease (PD). Background: Given the role of voice in language…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 405
- Next Page »